$36.47 0.02 (+0.05%)
2/9/2010 4:00 PM

Medivation, Inc. (MDVN)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.

Current Price $36.47 Mkt Cap $1.22B
Open $36.98 P/E Ratio 0.00
Prev. Close $36.45 Div. (Yield) N/A (N/A)
Daily Range $36.27 - $37.39 Volume 530,299
52-Wk Range $13.36 - $39.66 Avg. Daily Vol. 0

MDVN News and Commentary

Caps

How do you think MDVN will perform vs the S&P 500?

Add Stock to Watchlist

All Members

104 Outperform
36 Underperform
 

All-Star Members

37 Outperform
15 Underperform
 

Wall Street

7 Outperform
1 Underperform
 

Top MDVN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

henncoop (98.56)
Submitted June 14, 2007

shows some great promise with new alzhiemer's drug ...other drugs in the pipeline as well

rfreyermuth (< 20)
Submitted December 16, 2006

great management and great model

MDVN VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about MDVN.

Recs

0
Member Avatar docjohn18 (< 20) Submitted: 2/3/2010 9:37:29 PM : Outperform Start Price: $36.33 MDVN Score: +1.99

This is a superior drug discovery company with at least one and probably more than one blockbuster. I expect a takeover in 1-3 years,

Recs

0
Member Avatar Biotech2010 (40.47) Submitted: 1/26/2010 8:52:06 PM : Underperform Start Price: $33.60 MDVN Score: -10.33

38.12

Recs

0
Member Avatar Rzani (< 20) Submitted: 1/13/2010 1:45:03 PM : Outperform Start Price: $38.25 MDVN Score: +1.60

They will get approval.

Leaderboard

Find the members with the highest scoring picks in MDVN.

Score Leader

TrackRodmanRen

TrackRodmanRen (< 20) Score: +251.47

The Score Leader is the member with the highest score across all their picks in MDVN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
hopphys 76.47 11/20/2006 Outperform 5Y $13.18 +176.71% -18.85% +195.56
canoesail1 < 20 10/23/2006 Outperform 3M $13.15 +177.34% -16.67% +194.00
cysto 88.40 1/4/2008 Outperform NS $13.52 +169.75% -20.97% +190.72
hayrettin 77.58 7/8/2008 Outperform NS $13.14 +177.66% -12.53% +190.19
steveandteresa 50.68 10/11/2006 Outperform 5Y $13.35 +173.18% -15.60% +188.78
Dixie5346 62.46 10/11/2006 Outperform 1Y $13.35 +173.18% -15.60% +188.78
Hosannah 46.83 10/16/2006 Outperform 1Y $13.43 +171.56% -16.63% +188.19
1chuck 30.81 10/11/2006 Outperform 3Y $13.75 +165.14% -15.25% +180.40
bizunit 34.13 5/21/2008 Outperform 3Y $14.19 +157.01% -21.59% +178.60
MaximusPlexus < 20 11/29/2007 Outperform 1Y $14.33 +154.50% -23.59% +178.09

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackRothCapital 80.39 11/5/2009 Outperform NS $27.08 +34.68% +1.48% +33.20
TrackJPMorgan 84.76 10/30/2009 Outperform NS $25.59 +42.52% +1.93% +40.59
TrackHapoalim 23.78 3/5/2009 Outperform NS $15.57 +134.23% +55.73% +78.50
TrackLeerinkSwan 92.83 9/4/2008 Outperform NS $29.67 +22.92% -12.77% +35.69
TrackRodmanRen < 20 7/8/2008 Outperform NS $12.45 +192.93% -11.48% +204.41
TrackStanfordRes 85.54 1/29/2008 Outperform NS $17.85 +104.31% -17.90% +122.21
TrackRothCapital 80.39 1/17/2008 Outperform NS $15.77 +26.82% -43.73% +70.56 2/26/2009 @ $20.00
TrackBreanMurray 86.47 11/7/2007 Underperform NS $20.77 +75.59% -25.41% -101.00
TrackPacificGrow 89.01 10/31/2007 Outperform NS $21.49 +69.71% -27.02% +96.73
TrackRodmanRen < 20 10/4/2006 Outperform NS $10.19 +52.99% +5.93% +47.06 1/4/2007 @ $15.59

Featured Broker Partners